Immune checkpoint pathways are critical regulatory mechanisms of the immune system that maintain self-tolerance and modulate the duration and amplitude of physiological immune responses in peripheral tissues to minimize collateral tissue damage. In cancer, these pathways are often hijacked by tumor cells to evade immune surveillance.
